Application of a new improved model of a urethral catheter in the treatment and prevention of major pathological conditions of the urinary system

Cover Page

Cite item

Full Text

Abstract

From the time of the first clinical application to the present day, the urethral catheter is one of the most sought-after medical devices. Whether short-term catheterization or prolonged drainage of the bladder, the urethral catheter is an integral part of the treatment process in almost all nosologies. With all the potential benefits, finding a urethral catheter in the bladder cavity can lead to the formation of bacterial colonization, the formation of stones and secondary bacteremia, and to promote the growth of resistance to antibacterial drugs. The continuing high rate of nosocomial infection due to bladder drainage involves a number of requirements for the urethral catheter: it should be easy to use, convenient for patient and medical personnel, and, if possible, reduce the potential risk of infection of the urinary system. The introduction of urethral catheters impregnated with antibacterial, antimicrobial and antiseptic drugs significantly contributed to a decrease in the incidence of catheter-associated infection. This article describes the experience of using new models of the urethral catheter in reducing the risk and preventing the development of catheter-associated infection of the urinary system

About the authors

A. O Vasilyev

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: alexvasilyev@me.com
канд. мед. наук, ассистент каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. V Govorov

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dr.govorov@gmail.com
д-р мед. наук, проф. каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

M. G Schneiderman

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: innamike@lmi.net
канд. мед. наук, акушер-гинеколог, врач гинекологического отд-ния восстановительного лечения 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

P. I Bykov

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dr.bykov.pavel@gmail.com
ординатор каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

Yu. A Kim

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dockimyura@gmail.com
ординатор каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

D. Yu Pushkar

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: pushkardm@mail.ru
чл.-кор. РАН, проф., зав. каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

References

  1. Carr H.A. A short history of the Foley catheter: from handmade instrument to infection-prevention device. J Endourol 2000; 14 (1): 5-8.
  2. Foley F.E.B. Cystoscopic prostatectomy: a new procedure: preliminary report. J Urol 1929; 21: 289-306.
  3. Пушкарь Д.Ю., Сухих Г.Т., Шнейдерман М.Г. и др. Патент, регистрационный номер 2015105711 «Способ лечения и профилактики воспалительных процессов мочеиспускательного канала в раннем или позднем послеоперационном периодах».
  4. Пушкарь Д.Ю., Сухих Г.Т., Шнейдерман М.Г. и др. Патент, регистрационный номер 2015105715 «Урологический катетер».
  5. Васильев А.О., Говоров А.В., Рева И.А. и др. Альтернативные подходы к профилактике и лечению послеоперационных осложнений путем внедрения в практику новых моделей урологического катетера. Урология. 2016; 6: 5-10
  6. Васильев А.О., Говоров А.В., Ширяев А.А. и др. Роль уретрального катетера в развитии катетер-ассоциированной инфекции мочевыводящих путей. Урология. 2017; 6: 107-11.
  7. Сosterton J.W. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001; 9 (2): 50-2.
  8. Tenke P, Kovacs B, Bjerklund Johansen T.E. et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008; 31 (1): 68-78.
  9. Перепанова Т.С. Значение инфекций, обусловленных образованием биопленок, в урологической практике. Эффективная фармакотерапия. 2013; 37 (4): 18-27.
  10. Denstedt J.D, Wollin T.A, Reid G. Biomaterials used in urology: Current issues of biocompatibility, infection, and encrustation. J Endourol 1998; 12 (6): 493-500.
  11. Nickel J.C, McLean R.J.C. Bacterial biofilms in urology. Infect Urol 1998; 11: 169-75.
  12. Niel-Weise B.S, van den Broek P.J. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev 2005; 25: CD004201.
  13. Stickler D.J. Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr Opin Infect Dis 2000; 13: 389-93.
  14. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2004; 1: CD004013.
  15. Pickard R, Lam T, MacLennan G et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012; 1 (9857): 1927-35.
  16. Pickard R, Lam T, Maclennan G et al. Types of urethral catheter for reducing symptomatic urinary tract infections inhospitalised adults requiring short-term catheterisation: multicentrera domised controlled trial and economic evaluationof antimicrobialand antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technol Assess 2012; 16 (47): 1-197.
  17. Desai D.G, Liao K.S, Cevallos M.E. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol 2010; 184 (6): 2565-71.
  18. Rani S.A, Celeri C, Najafi R et al. Irrigation with N,N- dichloro-2,2-dimethyltaurine (NVC-422) in a citrate buffer maintains urinarycatheter patency in vitro and prevents encrustation by Proteus mirabilis. Urolithiasis 2016; 44 (3): 247-56.
  19. Kumar C.G, Sujitha P. Green synthesis of Kocuran-functionalized silver glyconanoparticles for use as antibiofilm coatings on silicone urethral catheters. Nanotechnology 2014; 25 (32): 325101.
  20. De Ridder D.J, Everaert K, Ferná́ndez L.G et al. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial. Eur Urol 2005; 48 (6): 991-5.
  21. Sarica S, Akkoc Y, Karapolat H et al. Comparison of the use of conventional, hydrophilic and gel-lubricated catheters with regard to urethral micro trauma, urinary system infection, and patient satisfaction in patients with spinal cord injury: a randomized controlled study. Eur J Phys Rehabil Med 2010; 46 (4): 473-9.
  22. Lange D, Elwood C.N, Choi K et al. Uropathogen interaction with the surface of urological stents using different surface properties. J Urol 2009; 182 (3): 1194-200.
  23. Hachem R, Reitzel R, Borne A et al. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 2009; 53 (12): 5145-9.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies